Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older
NCT04622592
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
209
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Instramuscular vaccine
Sponsor
Medicago